Feasibility of Short-Term Redifferentiation in Patients with Radioactive Iodine-Refractory Metastatic Thyroid Cancer. von Hinten J, Viering O, Bundschuh RA, Cagliyan F, et al. J Nucl Med 2025 Jun 5:jnumed.125.270055. doi: 10.2967/jnumed.125.270055.

Read + Share

Amedeo Smart

Independent Medical Education

von Hinten J, Viering O, Bundschuh RA, Cagliyan F, et al. Feasibility of Short-Term Redifferentiation in Patients with Radioactive Iodine-Refractory Metastatic Thyroid Cancer. J Nucl Med 2025 Jun 5:jnumed.125.270055. doi: 10.2967/jnumed.125.270055.
PMID: 40473458